CDK9-IN-39
CDK9-IN-39 (1-7a-B1) is an orally active inhibitor of cyclin-dependent kinase 9 (CDK9), with an IC50 value of 6.51 nM. By inhibiting the phosphorylation of RNA polymerase II at the Ser2 site, CDK9-IN-39 induces cell (apoptosis) and can be used for colorectal cancer research.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx00631-50gEcoli 50 µg (E. coli)
Recombinant Clostridium Perfringens pepA Protein (aa 1-493)
Sign In for Pricing
View Details EWC85586-01 50 mg
3- (Hydroxymethyl) -5-methyl-1,2-oxazole-4-carboxylic acid
Sign In for Pricing
View Details